If you're looking for an investment with a mature profit making medtech you're looking in the wrong column.
The company is currently valued at 12 million. That's in AUD.
So it's priced as a complete speculative medtech with virtually no prospects.
The question is: does this company have a much brighter future than the market is valuing? Or is it a dead duck?
I'm backing it as a turnaround.
Also, the market valuation will not be based on sales, but on the prospect of a future sale to a bigger company. So, the milestones are clear and baked into Nigel's options package: funded studies into adjuvant therapy with folfirinox (currently not authorised), percutaneous implantation, cholangioca, etc. These are all about extending the eligible population and the registration of the product. OSL and we shareholders are doing the hard yards of research and development risk so that a bigger fish who can take it over and generate those reliable sales (with much less risk) will pay for the privilege. I'm pretty sure this will not become a dividend paying, stable medtech.
It will be sold before that, if only because the ultimate FDA approval for pancreatic ca requires more capital than we can raise.
So the value inflections will be:
1. Successful folfirinox trial (and extension of label)
2. Successful percutaneous trial (and extension of label)
3. German GBA trial approval
4. FDA yes for cholangioca
5. TGA
There's nothing absolute there about sales imo.
I say hang on for the ride.
- Forums
- ASX - By Stock
- Ann: Two more PANCOSIL Trial treatments using OncoSil device
If you're looking for an investment with a mature profit making...
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.58M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $1.267K | 273.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
52 | 26394898 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 27725534 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
52 | 26394898 | 0.004 |
13 | 8143580 | 0.003 |
4 | 2757526 | 0.002 |
4 | 7800000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 27725534 | 24 |
0.006 | 16693590 | 18 |
0.007 | 28318316 | 22 |
0.008 | 2857500 | 5 |
0.009 | 1217500 | 2 |
Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
Last
0.4¢ |
  |
Change
0.000 ( 20.0 %) |
|||
Open | High | Low | Volume | ||
0.5¢ | 0.5¢ | 0.4¢ | 122495 | ||
Last updated 14.17pm 21/05/2024 ? |
Featured News
OSL (ASX) Chart |
The Watchlist
ATC
ALTECH BATTERIES LTD
Martin Stein, CFO
Martin Stein
CFO
Previous Video
Next Video
SPONSORED BY The Market Online